Titan Company Ltd has appointed Dr. S Vijayakumar as Chairman and Additional Director on its Board, effective June 29, 2026. The appointment follows a nomination received from Tamilnadu Industrial Development Corporation Limited (TIDCO), a co-promoter of the company. The Board approved the appointment via a circular resolution dated June 22, 2026.

Dr. S Vijayakumar will hold office as a Non-Executive, Non-Independent Director and is liable to retire by rotation. The company will seek shareholder approval for the appointment in the forthcoming Annual General Meeting, as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR).

Profile of the Appointee

Dr. S Vijayakumar is a 1993 batch IAS officer who has held key positions in various departments of the Government of Tamil Nadu. Presently, he serves as the Additional Chief Secretary to Government, Industries, Investment Promotion and Commerce Department. His previous roles include Additional Chief Secretary/Commissioner of Land Reforms in Chennai and Additional Chief Secretary/Chairman and Managing Director of Tamilnadu Urban Infrastructure Financial Services Limited.

Key Details of Appointment

The company disclosed that Dr. S Vijayakumar is not related to any Director, Key Managerial Personnel, or Promoters of Titan Company Ltd. Furthermore, he is not debarred from accessing the capital markets or restrained from holding the position of Director in any listed company by any order of SEBI or other authorities.

Titan Company Ltd has closed its trading window for designated persons and their immediate relatives starting June 23, 2026. The window will remain shut until 48 hours after the conclusion of the board meeting convened to consider the unaudited financial results for the quarter ending June 30, 2026. The restriction is implemented in accordance with the SEBI (Prohibition of Insider Trading) Regulations 2015 and the company's Code of Fair Disclosure and Conduct.

The specific date for the board meeting regarding the Q1FY27 results will be communicated separately. Until the trading window reopens, designated persons and their immediate relatives are prohibited from trading in the company's shares. This step ensures compliance with regulatory standards aimed at preventing insider trading during the period leading up to financial announcements.

The closure of the trading window is a standard procedural measure adopted by listed companies ahead of quarterly results. It is designed to maintain market integrity and prevent the misuse of unpublished price-sensitive information. The company has not yet disclosed the exact date for the board meeting, which will determine when the window reopens.

Key Details

The board meeting will focus on the unaudited financial results for the first quarter of FY27. Shareholders and market participants can expect the specific meeting date to be announced in due course. The company's adherence to regulatory timelines underscores its commitment to transparent corporate governance practices.